C12N 2501/11
Epidermal growth factor [egf]
Official title: Epidermal growth factor [EGF]
C12N2501/11 (Epidermal growth factor [egf]) appears on 975 US grants and 1,893 published applications in this corpus.
Search patents in C12N- Granted patents
- 975
- Published applications
- 1,893
- Assignees
- 863
- Inventors
- 3,255
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 7 | 0 |
| 1995 | 4 | 0 |
| 1996 | 14 | 0 |
| 1997 | 14 | 0 |
| 1998 | 20 | 0 |
| 1999 | 16 | 0 |
| 2000 | 18 | 0 |
| 2001 | 11 | 7 |
| 2002 | 14 | 37 |
| 2003 | 19 | 42 |
| 2004 | 10 | 47 |
| 2005 | 16 | 66 |
| 2006 | 25 | 67 |
| 2007 | 19 | 60 |
| 2008 | 16 | 62 |
| 2009 | 30 | 61 |
| 2010 | 26 | 70 |
| 2011 | 25 | 63 |
| 2012 | 39 | 70 |
| 2013 | 25 | 71 |
| 2014 | 44 | 44 |
| 2015 | 34 | 73 |
| 2016 | 46 | 81 |
| 2017 | 40 | 90 |
| 2018 | 58 | 73 |
| 2019 | 50 | 93 |
| 2020 | 42 | 85 |
| 2021 | 48 | 110 |
| 2022 | 40 | 118 |
| 2023 | 47 | 108 |
| 2024 | 52 | 104 |
| 2025 | 54 | 114 |
| 2026 | 40 | 77 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Induced pluripotent stem cell derived glial enriched progenitor cells for the treatment of white matter stroke6 Oct 2026US 12,751,976 B2The Regents of the University of California
- Immortalized keratinocytes, lentivirus for keratinocyte immortalization, and methods of use6 Oct 2026US 12,753,388 B2Regents of the University of Minnesota
- Ex vivo proliferation of epithelial cells29 Sep 2026US 12,747,425 B2Propagenix Inc.
- Method for preparing skin-derived pluripotent precursor cells1 Sep 2026US 12,723,232 B2Kao Corporation
- Method for the in vitro or ex vivo amplification of human adipose tissue stem cells1 Sep 2026US 12,723,234 B2Centre National de la Recherche Scientifique (CNRS)
- Methods and compositions related to platelet releasate and platelet-rich fibrin8 Oct 2026US 2026/0306546 A1Biobridge Global
- Xeno-free and transgene-free reprograming of mesenchymal stem cells toward neural progenitor cells1 Oct 2026US 2026/0297516 A1
- Composition for inducing direct differentiation of stem cells into corneal endothelial cells and method for inducing direct differentiation using same24 Sep 2026US 2026/0286295 A1The Asan Foundation
- Culture media and conditions for in vitro expansion and/or maturation of hepatocytes24 Sep 2026US 2026/0286311 A1Satellite Biosciences, Inc.
- Epithelial Stem Cells and Production and Uses thereof10 Sep 2026US 2026/0265690 A1Stemson Therapeutics Corp.
Most cited
By later US patents
- Three-dimensional cell and tissue culture system322US 4,963,489 AMarrow-Tech Incorporated · 1990
- In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny316US 5,750,376 ANeurospheres Holdings Ltd. · 1998
- Three-dimensional cartilage cultures289US 5,902,741 AAdvanced Tissue Sciences, Inc. · 1999
- In vitro growth and proliferation of multipotent neural stem cells and their progeny265US 5,851,832 ANeurospheres, Ltd. · 1998
- Three-dimensional cell and tissue culture system258US 5,443,950 AAdvanced Tissue Sciences, Inc. · 1995